MedPath

PAXLOVID 150 MG + 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

PAXLOVID 150 MG + 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

1221625001

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jan 31, 2022

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1221625001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (2)

NIRMATRELVIRActive
Quantity: 150 mg
Name: NIRMATRELVIR
RITONAVIRActive
Quantity: 100 mg
Name: RITONAVIR

ATC CLASSIFICATION (3)

J05A
J05AE
J05AE30

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.